Home
>
National Drug Code (NDC)
>
Ranitidine
Ranitidine - 60505-0026-3 - (ranitidine hydrochloride)
Drug Information of Ranitidine
| Product NDC: | 60505-0026 |
| Proprietary Name: | Ranitidine |
| Non Proprietary Name: | ranitidine hydrochloride |
| Active Ingredient(s): | 300 mg/1 & nbsp; ranitidine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ranitidine
| Product NDC: | 60505-0026 |
| Labeler Name: | Apotex Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074680 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970913 |
Package Information of Ranitidine
| Package NDC: | 60505-0026-3 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (60505-0026-3) |
NDC Information of Ranitidine
| NDC Code | 60505-0026-3 |
| Proprietary Name | Ranitidine |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (60505-0026-3) |
| Product NDC | 60505-0026 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ranitidine hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19970913 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
